Skip to main content
SANSTAR LIMITED logo

SANSTAR LIMITED — Investor Relations & Filings

Ticker · SANSTAR ISIN · INE08NE01025 LEI · 33580023LU1RLIZOKJ88 BSE.NS Manufacturing
Open in API
Filings indexed 134 across all filing types
Latest filing 2026-05-27 Investor Presentation
Country IN India
Listing BSE.NS SANSTAR

About SANSTAR LIMITED

https://sanstar.in/

Sanstar Limited specializes in the manufacture of plant-based specialty products and ingredient solutions derived from maize. The product portfolio encompasses liquid glucose, dried glucose solids, maltodextrin powder, dextrose monohydrate, and native maize starch, alongside specialized modified starches. The company also produces co-products including maize germ, maize gluten, and maize bran. These products are utilized across diverse applications such as food and beverage production, animal nutrition, pharmaceuticals, textiles, and paper manufacturing. With a focus on large-scale production and global distribution, the company provides essential raw materials and functional ingredients to a broad range of technical and consumer-facing sectors.

Recent filings

Filing Released Lang Actions
Investor Presentation
Investor Presentation Classification · 92% confidence The document is a press release under SEBI LODR Reg.30 enclosing a detailed “Q4 and FY2026 Earnings Presentation” with key financial results, business overview slides, capacity details and commentary—not the full statutory annual report. It is a slide‐based investor presentation of quarterly/annual results rather than a standalone earnings press release summary (ER) or full regulatory filing. Hence, it should be classified as an Investor Presentation (IP).
2026-05-27 English
Press Release
Investor Presentation Classification · 91% confidence The document begins with a listing‐related cover letter to BSE and NSE under SEBI LODR Reg. 30 submitting an enclosed press release of the audited Q4 and FY2026 results. The bulk of the text is a slide‐style deck (“Earnings Presentation”) with charts, bullet points on market leadership, capacity, financial performance, outlook, and strategy. This is not the signed statutory financial statements (10‐K/IR), nor a simple press release summary (ER). It is a detailed investor slide presentation. Therefore, it is classified as an Investor Presentation (IP).
2026-05-27 English
Press Release for the Standalone Audited Financial Results for the Fourth Quarter and Year Ended on 31st March, 2026
Investor Presentation Classification · 92% confidence The document begins with a SEBI Listing Obligations letter submitting a press release and then presents a slide‐style deck titled “Q4 and FY2026 Earnings Presentation.” It includes detailed investor‐style content: market leadership, capacity expansion, product portfolios, strategic outlook, and comprehensive financial metrics and charts. This goes beyond a brief earnings release (key headline figures) and matches the characteristics of a detailed investor presentation. Therefore, it is classified as an Investor Presentation.
2026-05-27 English
Intimation for Closure of Trading window
Regulatory Filings Classification · 85% confidence The document is a formal notice under SEBI Listing Regulations informing stock exchanges of an upcoming board meeting to consider matters including a fundraising proposal. It does not itself constitute a financial report, earnings release, or change in board/management, nor does it publish any substantive financial statements. Instead, it is a regulatory announcement to the exchanges. Thus, it falls under the general regulatory filings (“RNS”) category as a compliance/announcement filing.
2026-05-25 English
Trading Window
Regulatory Filings Classification · 75% confidence The document is a formal notice to stock exchanges (BSE and NSE) of a forthcoming board meeting under SEBI Listing Regulations, covering agenda items such as a proposal for fundraising and closure of the trading window. It is not the actual fundraising announcement, proxy solicitation, or board change announcement, but rather a compliance-based intimation. It contains no substantive financial data or report, nor does it announce voting results or file executive certifications. Therefore, it falls under a general regulatory filing (RNS).
2026-05-25 English
Sanstar Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 28/05/2026 ,inter alia, to consider and approve Proposal for fund raising by way of ....
Regulatory Filings Classification · 79% confidence The document is a statutory prior intimation of a Board meeting under SEBI Listing Regulations, advising exchanges of the date and agenda (including a proposed fundraising by share issuance). It contains no financial statements, no management change, and no completed capital transaction—it is a regulatory notification. Therefore it does not qualify as a financial report, fundraising completion announcement, or board change notice; it is best classified under general regulatory filings (RNS).
2026-05-25 English

Browse filings by year

3 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.